A Pilot Study of Pembrolizumab and Neoadjuvant Radiation for Large, High-Grade Soft Tissue Sarcomas
Phase of Trial: Phase I/II
Latest Information Update: 23 Apr 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Jan 2018 Status changed from not yet recruiting to recruiting.
- 27 Nov 2017 Planned End Date changed from 16 Oct 2022 to 15 Jun 2019.
- 27 Nov 2017 Planned primary completion date changed from 16 Oct 2022 to 15 Jun 2019.